DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Growth in Short Interest

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 796,100 shares, a growth of 11.6% from the June 30th total of 713,600 shares. Approximately 4.5% of the shares of the stock are sold short. Based […]

Related Keywords

Randall Michael Giuffre ,Catalyst Financial Partners ,Dimensional Fund Advisors ,Nasdaq ,Citadel Advisors ,Renaissance Technologies ,Diamedica Therapeutics Inc ,Securities Exchange Commission ,Diamedica Therapeutics ,Get Free Report ,Koch Thomas Von ,Director Randall Michael Giuffre ,Exchange Commission ,Street Corp ,Fund Advisors ,Financial Partners ,Medica Therapeutics ,Medica Therapeutics Inc ,Diamedica Therapeutics Daily ,Nasdaq Dmac ,Sdmac ,Medical ,Stocks ,Options ,Put ,Call ,